SRCAP
protein-codingSnf2 related CREBBP activator protein, the group of Small nucleolar RNA protein coding host genes|SRCAP complex
Gene summary
This gene encodes the core catalytic component of the multiprotein chromatin-remodeling SRCAP complex. The encoded protein is an ATPase that is necessary for the incorporation of the histone variant H2A.Z into nucleosomes. It can function as a transcriptional activator in Notch-mediated, CREB-mediated and steroid receptor-mediated transcription. Mutations in this gene cause Floating-Harbor syndrome, a rare disorder characterized by short stature, language deficits and dysmorphic facial features. [provided by RefSeq, Feb 2012]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~43.2 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0859202
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0859202
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0007621
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0007621
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0859202
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0007621
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0007621
Submitter: ClinGen
*SRCAP* was first reported in relation to autosomal dominant Floating Harbor Syndrome (FHS) in 2012 (Hood et al., PMID: 22265015). A rare genetic disorder, FHS is characterized by short stature, delayed bone age, delayed speech development, and distinctive facial features – the face is triangular with deep-set eyes, long eyelashes, bulbous nose, wide columella, short philtrum, and thin lips. Additional phenotypes including mild to moderate intellectual disability have also been reported. The specific phenotypes and severity of FHS vary greatly from one person to another and also by age. Fourteen variants (frameshift (9) and nonsense (5)) mostly de novo (9), reported in 14 probands in 5 publications are included in this curation (PMIDs: 22265015, 22965468, 25433523, 23621943, 30425916). Two of the variants, c.7330C>T (p.Arg2444*) and c.7303C>T (p.Arg2435*) on exon 34, are recurrent and have been reported in sixteen and ten unrelated individuals, respectively (PMID: 22265015, 22965468, 25433523, 30425916, 23621943). The mechanism of pathogenicity is reported as haploinsufficiency. While more evidence is available in the literature, the maximum score for genetic evidence (12 points) has been reached. In summary, there is definitive evidence to support the relationship between *SRCAP* and Floating Harbor Syndrome. This has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time. This classification was approved by the ClinGen Intellectual Disability and Autism expert panel on August 1, 2023 (SOP Version 9).
Inheritance Pattern: AD
Disease ID:MONDO:0007621
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0859202
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0007621
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Genitourinary; Musculoskeletal; Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to SRCAP variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_006662.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 16 | 566 | 5 | 587 | ||
| missense | 6 | 1327 | 204 | 2 | 1539 | |
| nonsense | 16 | 21 | 7 | 44 | ||
| start loss | 0 | |||||
| frameshift | 28 | 46 | 7 | 81 | ||
| splice donor/acceptor (+/-2bp) | 2 | 8 | 7 | 17 | ||
| Total | 46 | 81 | 1364 | 770 | 7 | 2268 |
Highest pathogenic variant AF is 0.00018591479
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_006653.2 | 32 | MANE Select | |
| Ensembl | ENSP00000262518.4 | 32 | MANE Select | |
| Ensembl | ENSP00000405186.3 | 32 | Standard | |
| Ensembl | ENSP00000483329.1 | 18 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Pathways Affected in Adenoid Cystic Carcinoma
Biological Process
- chromatin remodeling
- regulation of transcription by RNA polymerase II
- viral process
- gene silencing
- histone acetylation
Molecular Function
- DNA binding
- transcription coactivator activity
- helicase activity
- histone acetyltransferase activity
- protein binding
Cellular Component
- Swr1 complex
- nucleus
- nucleoplasm
- Golgi apparatus
- nuclear body
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000262518
- Coding exons
- 32
- Length
- 46073
- Individuals with no LoFs
- 125732
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 16
- Defined
- 125748
- p
- 0.0000636
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 2.13 | 1634 | 1.89e+3 | 0.862 | 0.000118 | 20343 |
| Missense (PolyPhen) | 147 | 225.75 | 0.65117 | 2176 | ||
| Synonymous | -3.11 | 850 | 742 | 1.15 | 0.0000419 | 7482 |
| Loss of Function | 9.81 | 6 | 124 | 0.0485 | 0.00000754 | 1310 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00018 | 0.00018 | rare |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0.00020 | 0.00020 | rare |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0.000046 | 0.000046 | rare |
| European (Non-Finnish) | 0.000071 | 0.000062 | rare |
| South Asian | 0.000098 | 0.000098 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Catalytic component of the SRCAP complex which mediates the ATP-dependent exchange of histone H2AZ/H2B dimers for nucleosomal H2A/H2B, leading to transcriptional regulation of selected genes by chromatin remodeling. Acts as a coactivator for CREB-mediated transcription, steroid receptor-mediated transcription, and Notch-mediated transcription. {ECO:0000269|PubMed:10347196, ECO:0000269|PubMed:11522779, ECO:0000269|PubMed:14500758, ECO:0000269|PubMed:16024792, ECO:0000269|PubMed:16634648, ECO:0000269|PubMed:17617668}.;
- Disease
- DISEASE: Floating-Harbor syndrome (FLHS) [MIM:136140]: A rare genetic disorder characterized by proportionate short stature, delayed bone age, delayed speech development, and typical facial features. The face is triangular with deep-set eyes, long eyelashes, bulbous nose, wide columella, short philtrum, and thin lips. {ECO:0000269|PubMed:22265015}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.0771
Intolerance Scores
- LoFtool
- 0.00579
- RVIS EVS
- -4.14
- RVIS percentile EVS
- 0.15
Essentials
- Essential (CRISPR)
- E
- Essential (CRISPR2)
- E
- Essential (gene trap)
- E
- Indispensability pred.
- E
- Indispensability score
- 0.847
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |